Coya Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-4.31-4.5-6.90-3.75
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$-1.37$-1.32$-0.86$-1.58

Historical Multiples (2020 – 2023)

2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-60.33-9.08-3.21-9.42N/A-6.14
Price/Sales ratio
N/AN/AN/A12.54N/AN/A
Price/Book Value ratio
5.3212.14-5.612.11N/A3.26
Price/Cash Flow ratio
-113.05-11.33-6.51-6.73N/A-8.92
Price/Free Cash Flow ratio
-113.05-10.94-6.51-6.73N/A-8.72
Price/Earnings Growth ratio
N/A-0.01-0.010.20N/A-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A99.54%N/AN/A
Operating Profit Margin
N/AN/AN/A-131.67%N/AN/A
Pretax Profit Margin
N/AN/AN/A-121.02%N/AN/A
Net Profit Margin
N/AN/AN/A-133.08%N/AN/A
Effective Tax Rate
0.09%0.43%-19.86%-9.96%N/A-9.71%
Return on Assets
-8.38%-101.63%-174.82%-19.35%N/A-138.22%
Return On Equity
-8.83%-133.66%174.86%-22.41%N/A20.60%
Return on Capital Employed
-8.36%-133.66%-214.61%-21.82%N/A-174.13%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/A
Quick Ratio
19.563.991.878.15N/A2.93
Cash ratio
19.503.771.556.45N/A2.66
Days of Sales Outstanding
N/AN/AN/A456.08N/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/A456.08N/AN/A
Days of Payables Outstanding
N/A19.40K24.21K15.41KN/A21.80K
Cash Conversion Cycle
N/AN/AN/A-14.96KN/AN/A
Debt Ratios
Debt Ratio
N/AN/A1.54N/AN/A0.77
Debt Equity Ratio
N/AN/A-1.54N/AN/A-0.77
Long-term Debt to Capitalization
N/AN/A2.83N/AN/A1.41
Total Debt to Capitalization
N/AN/A2.83N/AN/A1.41
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/A-0.55N/AN/A-0.27
Company Equity Multiplier
1.051.31-1.001.15N/A0.15
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A-1.86N/AN/A
Free Cash Flow / Operating Cash Flow Ratio
11.0311N/A1.01
Cash Flow Coverage Ratio
N/AN/A-0.55N/AN/A-0.27
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A